24 HR desvenlafaxine succinate 100 MG Extended Release Oral Tablet [Pristiq]
- RxCUI
- 790267
- RxNorm name
- 24 HR desvenlafaxine succinate 100 MG Extended Release Oral Tablet [Pristiq]
- Display name
- 24 HR desvenlafaxine succinate 100 MG Extended Release Oral Tablet [Pristiq]
- Full name
- 24 HR desvenlafaxine succinate 100 MG Extended Release Oral Tablet [Pristiq]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:47
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pristiq Extended-Release | DESVENLAFAXINE SUCCINATE | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 0f43610c-f290-46ea-d186-4f998ed99fce | 2026-04-28 | Boxed warning, Warnings, Adverse reactions | 790267 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 0f43610c-f290-46ea-d186-4f998ed99fce | Pristiq 100 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR desvenlafaxine succinate 100 MG Extended Release Oral Tablet [Pristiq] [SBD] · 24 HR Pristiq 100 MG Extended Release Oral Tablet [SY] · Pristiq 100 MG (as desvenlafaxine succinate 152 MG) 24 HR Extended Release Oral Tablet [SY] | 4 | 67 | These highlights do not include all the information needed to use PRISTIQ safely and effectively. See full prescribing information for PRISTIQ. PRISTIQ ® (desvenlafaxine) Extended-Release Tablets, for oral use Initial U.S. Approval: 2008 | 20260428 |